HIL-18BP therapy did not drastically reduce the CDK3 review synovial inflammation score on the initial
HIL-18BP therapy did not drastically reduce the CDK3 review synovial inflammation score on the initial arthritic paw at any in the tested doses (Table 1). Interestingly, when the other paws…